Markets Negative Despite Jump In New Home Sales

On the upside

Nymox Pharmaceutical (Nasdaq: NYMX) reported that its NX-1207 treatment for enlarged prostates reduced liver cancer tumors in rodents.

Myriad Genetics (Nasdaq: MYGN) reported sharply higher fourth quarter earnings prompting an upgrade.

Alcatel-Lucent (NYSE: ALU) will provide China Telecom with an IP backbone and maintain the network across ten provinces.

On the downside

While Dycom Industries (NYSE: DY) reported higher fourth quarter earnings, the telecommunications contractor swung to a loss for the year.

Thompson Creek (NYSE: TC) will sell 15.5 million common shares to a syndicate of underwriters to raise approximately C$217 million.

Although third quarter earnings for Canadian Imperial Bank of Commerce (NYSE: CM) rose, the results fell short of estimates as loan loss provisions soared.

In the broad market, declining issues outpaced advancers by a margin of nearly 5 to 3 on the NYSE and by more than 5 to 4 on Nasdaq. The Russell 2000 which tracks small cap stocks lost 2 points to 581.